Please login to the form below

Not currently logged in
Email:
Password:

rosuvastatin

This page shows the latest rosuvastatin news and features for those working in and with pharma, biotech and healthcare.

AZ divests European rights for cholesterol med Crestor to Grünenthal

AZ divests European rights for cholesterol med Crestor to Grünenthal

Grünenthal will gain the rights to Crestor (rosuvastatin) in the EU, excluding Spain and the UK, and its associated brands for a total consideration of up to $350m.

Latest news

More from news
Approximately 4 fully matching, plus 59 partially matching documents found.

Latest appointments

  • Evan Lippman joins Aileron Therapeutics Evan Lippman joins Aileron Therapeutics

    Highlights of his career include a spell as executive director at AstraZeneca where he led on huge brands such as Crestor (rosuvastatin calcium) and Nexium (esomeprazole) and heading US business development

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...